GENETIC ARCHITECTURE OF METABOLIC SYNDROME IN WOMEN DURING THE MENOPAUSAL TRANSITION
Article Sidebar
Main Article Content
Abstract
The menopausal transition is associated with profound endocrine and metabolic changes that increase susceptibility to metabolic syndrome. Although estrogen deficiency is a major contributing factor, accumulating evidence indicates that genetic predisposition plays a decisive role in determining metabolic adaptability in menopausal women.
This article synthesizes contemporary findings on genetic determinants involved in the development of metabolic syndrome during menopause. Particular attention is given to genes regulating insulin signaling, adipokine secretion, lipid metabolism, inflammatory responses, oxidative stress, and mitochondrial function. The interaction between genetic background, hormonal decline, and environmental influences is analyzed as a key mechanism underlying metabolic maladaptation.
Recognition of genetic susceptibility patterns may facilitate early identification of high-risk individuals and support the development of personalized preventive and therapeutic strategies in menopausal healthcare.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Alberti, K.G.M.M. et al., 2009. Harmonizing the metabolic syndrome. Circulation, 120(16), pp.1640–1645.
2.Carr, M.C., 2003. The emergence of the metabolic syndrome with menopause. The Journal of Clinical Endocrinology & Metabolism, 88(6), pp.2404–2411.
3.Grundy, S.M., 2016. Metabolic syndrome update. Trends in Cardiovascular Medicine, 26(4), pp.364–373.
4.Lovejoy, J.C. et al., 2008. Increased visceral fat and decreased energy expenditure during menopause. The Journal of Clinical Endocrinology & Metabolism, 93(11), pp.4232–4238.
5.Mauvais-Jarvis, F., 2015. Estrogen and androgen receptors in metabolic regulation. Molecular Metabolism, 4(5), pp.372–379.
6.Petersen, K.F. and Shulman, G.I., 2018. Mechanisms of insulin resistance. Physiological Reviews, 98(4), pp.2133–2223.
7.Rosen, E.D. and Spiegelman, B.M., 2014. Adipocytes as regulators of energy balance. Nature, 444(7121), pp.847–853.
8.Ryan, A.S., 2012. Insulin resistance and menopause. Current Opinion in Endocrinology, 19(4), pp.280–285.
9.Wildman, R.P. et al., 2012. Lipid changes during the menopausal transition. Journal of Clinical Lipidology, 6(6), pp.631–639.